Opko Health’s Pfizer Deal Set To Ignite Shares
When a stock that’s relatively stable suddenly sees an 8.3% one-day spike – and on volume that’s over five times higher than its regular daily average – it’s time to pay attention. That’s precisely what happened to biopharmaceutical and diagnostics company Opko Health (OPK), on Monday. It’s been an okay year for the Miami-based firm,…